565
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      LUPUS PANNICULITIS AS AN INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

      case-report
      ,
      Indian Journal of Dermatology
      Medknow Publications
      Hydroxychloroquine, lupus panniculitis, SLE

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In May, 2003, a 28-year-old female presented with large non-healing ulcers on face, trunk and limbs covered with black hemorrhagic crust. There were no other systemic manifestations. Diagnosis of lupus panniculitis was considered on clinical and histopathological grounds. The lesions healed completely, with scarring, with systemic corticosteroid, hydroxychloroquine and topical 2% mupirocin. She came again in November, 2005, with malar rash, joint pain, scarring alopecia of the scalp and albuminuria. Her ANA, AntidsDNA came positive and diagnosed as having systemic lupus erythematosus (SLE). She responded well to systemic corticosteroid, antimalarial and topical antibacterial. The evolution of lupus panniculitis is slow and characterized by regression of the inflammatory lesions when treated with antimalarial drugs. The lupus panniculitis generally has a favorable course.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

          Hydroxychloroquine is used by 35% of SLE patients enrolled in the Baltimore Lupus Cohort. Eighty per cent of patients who took hydroxychloroquine at cohort entry remain on it six years later. In addition to its role for disease manifestations of lupus, hydroxychloroquine may be indicated for the prevention of disease or treatment-induced complications, including hyperlipidemia, diabetes mellitus, liver function test elevation and thrombosis.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Current treatment of cutaneous lupus erythematosus.

              V Werth (2001)
              Cutaneous lupus erythematosus has a variety of clinical presentations, but treatment is similar for the different forms. The antimalarials remain the cornerstone of treatment because of their effectiveness and safety. Optimal use of the antimalarials as well as alternative therapy options are discussed.
                Bookmark

                Author and article information

                Journal
                Indian J Dermatol
                IJD
                Indian Journal of Dermatology
                Medknow Publications (India )
                0019-5154
                1998-3611
                Jan-Mar 2010
                : 55
                : 1
                : 99-101
                Affiliations
                From the Department of Skin V. D., Medical College, Vadodara - 390 001, Gujarat, India.
                Author notes
                Address for correspondence: Dr. Raksha M. Patel, R-3, Doctors Quarters, Jail Road, Vadodara-1, Gujarat, India. E-mail: rakshamp@ 123456yahoo.co.in
                Article
                IJD-55-99
                10.4103/0019-5154.60364
                2856385
                20418989
                9b8c57b2-315f-4b9b-af57-1ca582a9c880
                © Indian Journal of Dermatology

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : August 2007
                : August 2009
                Categories
                Case Report

                Dermatology
                sle,lupus panniculitis,hydroxychloroquine
                Dermatology
                sle, lupus panniculitis, hydroxychloroquine

                Comments

                Comment on this article